_PRIVATE_LIMITED_388666.webp)
Muscle House (I) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.76 Cr
as on 17-07-2024
- Satisfied Charges ₹ 12.81 Cr
as on 17-07-2024
- Revenue -12.53%
(FY 2023)
- Profit -29.98%
(FY 2023)
- Ebitda -8.36%
(FY 2023)
- Net Worth 27.30%
(FY 2023)
- Total Assets 34.55%
(FY 2023)
About Muscle House (I)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹20.76 Cr. The company has closed loans amounting to ₹12.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aman Vachher and Aniket Vachher serve as directors at the Company.
- CIN/LLPIN
U74999DL2016PTC302019
- Company No.
302019
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Muscle House (I) Private Limited offer?
Muscle House (I) Private Limited offers a wide range of products and services, including Common Disease Medicines, Steroid.
Who are the key members and board of directors at Muscle House (I)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aman Vachher  | Director | 25-Aug-2017 | Current |
| Aniket Vachher | Director | 24-Jun-2016 | Current |
Financial Performance of Muscle House (I).
Muscle House (I) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.53% decrease. The company also saw a substantial fall in profitability, with a 29.98% decrease in profit. The company's net worth Soared by an impressive increase of 27.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Muscle House (I)?
In 2023, Muscle House (I) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
One Science Nutrition (India) LlpActive 3 years 6 monthsAman Vachher and Aniket Vachher are mutual person
- Healthyline Lifesciences Private LimitedActive 2 years 5 months
Aman Vachher and Aniket Vachher are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Aug 2021 | ₹20.42 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Feb 2021 | ₹3.38 M | Open |
Hdfc Bank Limited Creation Date: 28 Jun 2019 | ₹8.81 Cr | Satisfied |
How Many Employees Work at Muscle House (I)?
Unlock and access historical data on people associated with Muscle House (I), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Muscle House (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Muscle House (I)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
